Mia's Feed
Medical News & Research

Winning Experiences and Social Rank Influence Brain Pathways to Reduce Drug-Seeking Behavior

Winning Experiences and Social Rank Influence Brain Pathways to Reduce Drug-Seeking Behavior

Share this article

New research reveals how winning social experiences can reshape brain dopamine systems, reducing drug-seeking behavior by enhancing neural control mechanisms. Learn how social rank influences addiction vulnerability.

2 min read

Research from the Chinese Academy of Sciences has uncovered neural mechanisms linking social dominance to addiction vulnerability. Published in Nature Neuroscience, the study demonstrates how positive social experiences, or 'winning experiences,' can modify brain dopamine pathways, decreasing the impulse to seek drugs such as methamphetamine (METH).

The team, led by Professor Zhu Yingjie, utilized advanced techniques like fiber photometry, cyclic voltammetry, optogenetics, and volumetric imaging to study dopamine system differences in rodents with distinct social ranks. They discovered that an animal’s social status influences its tendency toward drug-seeking behaviors through two key pathways:

  • The mesolimbic pathway, which projects dopamine to the nucleus accumbens (NAc), increases reward perception and drug craving.
  • The mesocortical pathway, sending dopamine to the medial prefrontal cortex (mPFC), supports cognitive control and resistance to addiction.

Low-ranking mice exhibit a hyperactive reward pathway and a weaker control pathway—akin to a car with a weak brake—making them more susceptible to drug seeking. Conversely, dominant mice display a balanced system with better control, helping resist addiction.

Interventions showed that reducing dopamine activity in the NAc of low-ranking mice led to less methamphetamine intake. Damage to the mPFC in high-ranking mice increased drug-seeking, while stimulating this area through optogenetics reduced their desire for METH and improved social dominance.

Crucially, introducing winning experiences in low-ranking mice elevated their social standing and led to reduced drug-seeking behaviors. These behavioral changes correlated with structural and functional remodeling of both dopamine pathways, suggesting that social and neural plasticity can mitigate addiction risks.

Prof. Zhu emphasized that enhancing social success or simulating rewarding experiences could ‘reinforce the brakes and weaken the accelerator’ in brain circuits, offering a promising direction for noninvasive neurostimulation therapies aimed at addiction prevention and treatment.

This groundbreaking research underscores the importance of social factors in addiction neurobiology and opens new paths for interventions based on social and neural reinforcement.

Source: medicalxpress.com

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Breakthrough in Cell Death Research Paves Way for Innovative Treatments for Neurodegenerative Diseases

A groundbreaking study uncovers a small molecule that inhibits a key protein involved in neuronal cell death, offering new hope for treatments of neurodegenerative diseases like Parkinson's and Alzheimer's.

President Trump Announces Plan to Sign Executive Order Aiming to Reduce US Drug Prices

President Trump announced plans to sign an executive order implementing a 'Most Favored Nation' policy, aiming to significantly reduce prescription drug prices in the US by linking them to the lowest prices paid internationally.

Kennedy's Vaccine Committee Endorses Preservative-Free Flu Shots for Fall

Kennedy's vaccine advisory panel recommends only preservative-free flu vaccines for all individuals aged 6 months and older, amid ongoing vaccine ingredient concerns and recent policy shifts.

Revolutionary Brain-to-Computer 'Electroceuticals' Show Promise in Restoring Cognitive Functions

Emerging research demonstrates how brain-to-computer electroceuticals can improve learning and cognitive flexibility, paving the way for novel therapies for cognitive disorders.